FIELD: medicine.
SUBSTANCE: method and composition for treating vitamin B12 deficiency in mammals who are not treatable by peroral introduction of vitamin B12, which include preparation of pharmaceutical composition for peroral introduction, which contains vitamin B12 and at least one substance, selected from group, consisting of N-[-8-(2-hydroxybenzoyl)amino]caprylic acid and its pharmaceutically acceptable salts, then introduction of pharmaceutical composition to subject.
EFFECT: increased efficiency of treatment of vitamin B12 deficiency.
23 cl, 3 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ORAL THERAPY OF VITAMIN B DEFICIENCY | 2011 |
|
RU2576511C2 |
| SOLID COMPOSITIONS CONTAINING GLP-1 AGONIST AND N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID SALT AND LUBRICANT | 2019 |
|
RU2807183C2 |
| ORAL DOSING OF GLUCAGON-LIKE PEPTIDE-1 COMPOUNDS | 2014 |
|
RU2671406C2 |
| GLP-1 PEPTIDES COMPOSITIONS AND THEIR PRODUCTION | 2013 |
|
RU2641198C2 |
| SOLID COMPOSITIONS CONTAINING GLP-1 AGONIST AND N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID SALT | 2019 |
|
RU2804318C2 |
| SOLID COMPOSITIONS CONTAINING AGONIST TO GLP AND SALT OF N-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID | 2011 |
|
RU2600440C2 |
| PERORAL INTRODUCTION OF CALCITONIN | 2003 |
|
RU2355417C2 |
| APPLICATION OF CALCITONIN FOR TREATING RHEUMATOID ARTHRITIS | 2006 |
|
RU2453330C2 |
| METHODS FOR PREPARING ACYCLOVIR FORMULATION | 2005 |
|
RU2406504C2 |
| PRODUCT FOR ORAL DELIVERY | 2016 |
|
RU2732498C2 |
